WO2006120851A1 - Agent destine a communiquer des fonctions a des produits textiles - Google Patents
Agent destine a communiquer des fonctions a des produits textiles Download PDFInfo
- Publication number
- WO2006120851A1 WO2006120851A1 PCT/JP2006/308214 JP2006308214W WO2006120851A1 WO 2006120851 A1 WO2006120851 A1 WO 2006120851A1 JP 2006308214 W JP2006308214 W JP 2006308214W WO 2006120851 A1 WO2006120851 A1 WO 2006120851A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivative
- hydroxyproline
- products
- proline
- hydroxy
- Prior art date
Links
- 239000004753 textile Substances 0.000 title claims abstract description 9
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 88
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 58
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 57
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 53
- 150000003839 salts Chemical class 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 25
- 239000004744 fabric Substances 0.000 claims abstract description 15
- 230000000474 nursing effect Effects 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 239000000835 fiber Substances 0.000 claims description 29
- 239000011230 binding agent Substances 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 230000002265 prevention Effects 0.000 abstract description 8
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000009759 skin aging Effects 0.000 abstract description 4
- 230000029663 wound healing Effects 0.000 abstract description 4
- 206010012438 Dermatitis atopic Diseases 0.000 abstract description 2
- 201000008937 atopic dermatitis Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- -1 butyrinole Chemical group 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 229960002429 proline Drugs 0.000 description 10
- 229920000742 Cotton Polymers 0.000 description 8
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- BJBUEDPLEOHJGE-UHFFFAOYSA-N 3-hydroxyproline Chemical compound OC1CCNC1C(O)=O BJBUEDPLEOHJGE-UHFFFAOYSA-N 0.000 description 4
- 206010011985 Decubitus ulcer Diseases 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- PMMYEEVYMWASQN-IMJSIDKUSA-N trans-4-Hydroxy-L-proline Natural products O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 4
- BAPRUDZDYCKSOQ-RITPCOANSA-N (2s,4r)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CC(=O)N1C[C@H](O)C[C@H]1C(O)=O BAPRUDZDYCKSOQ-RITPCOANSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 244000235659 Rubus idaeus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 235000021013 raspberries Nutrition 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- PMMYEEVYMWASQN-IUYQGCFVSA-N trans-4-hydroxy-D-proline Chemical compound O[C@@H]1CN[C@@H](C(O)=O)C1 PMMYEEVYMWASQN-IUYQGCFVSA-N 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- BJBUEDPLEOHJGE-BKLSDQPFSA-N 3-hydroxy-L-proline Chemical compound OC1CCN[C@@H]1C(O)=O BJBUEDPLEOHJGE-BKLSDQPFSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- FGMPLJWBKKVCDB-SCSAIBSYSA-N (2r)-1-hydroxypyrrolidine-2-carboxylic acid Chemical compound ON1CCC[C@@H]1C(O)=O FGMPLJWBKKVCDB-SCSAIBSYSA-N 0.000 description 1
- BJBUEDPLEOHJGE-SRBOSORUSA-N (2r)-3-hydroxypyrrolidine-2-carboxylic acid Chemical compound OC1CCN[C@H]1C(O)=O BJBUEDPLEOHJGE-SRBOSORUSA-N 0.000 description 1
- WDQFANGFRWWMLD-PHDIDXHHSA-N (2r,4r)-4-hydroxy-1-propanoylpyrrolidine-2-carboxylic acid Chemical compound CCC(=O)N1C[C@H](O)C[C@@H]1C(O)=O WDQFANGFRWWMLD-PHDIDXHHSA-N 0.000 description 1
- WDQFANGFRWWMLD-RITPCOANSA-N (2s,4r)-4-hydroxy-1-propanoylpyrrolidine-2-carboxylic acid Chemical compound CCC(=O)N1C[C@H](O)C[C@H]1C(O)=O WDQFANGFRWWMLD-RITPCOANSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- QEYKLZYTRRKMAT-UHFFFAOYSA-N 2-methyl-3h-1,2-thiazole 1-oxide Chemical compound CN1CC=CS1=O QEYKLZYTRRKMAT-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000510032 Ellipsaria lineolata Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- 101800000021 N-terminal protease Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BJBUEDPLEOHJGE-IUYQGCFVSA-N cis-3-hydroxy-D-proline zwitterion Chemical compound O[C@H]1CCN[C@H]1C(O)=O BJBUEDPLEOHJGE-IUYQGCFVSA-N 0.000 description 1
- BJBUEDPLEOHJGE-DMTCNVIQSA-N cis-3-hydroxy-L-proline Chemical compound O[C@@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-DMTCNVIQSA-N 0.000 description 1
- PMMYEEVYMWASQN-QWWZWVQMSA-N cis-4-hydroxy-D-proline Chemical compound O[C@H]1C[NH2+][C@@H](C([O-])=O)C1 PMMYEEVYMWASQN-QWWZWVQMSA-N 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920006284 nylon film Polymers 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 229960005113 oxaceprol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 150000003147 proline derivatives Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- BJBUEDPLEOHJGE-QWWZWVQMSA-N trans-3-hydroxy-D-proline Chemical compound O[C@@H]1CCN[C@H]1C(O)=O BJBUEDPLEOHJGE-QWWZWVQMSA-N 0.000 description 1
- BJBUEDPLEOHJGE-IMJSIDKUSA-N trans-3-hydroxy-L-proline Chemical compound O[C@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-IMJSIDKUSA-N 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/325—Amines
- D06M13/342—Amino-carboxylic acids; Betaines; Aminosulfonic acids; Sulfo-betaines
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/35—Heterocyclic compounds
- D06M13/352—Heterocyclic compounds having five-membered heterocyclic rings
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
- D21H27/002—Tissue paper; Absorbent paper
Definitions
- the present invention relates to a functional imparting agent for a fiber product, a functional fiber product, and a method for producing the functional fiber product, which contains hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
- Hydroxyproline an N-acylated derivative of hydroxyproline, or a salt thereof is known as an amino acid exhibiting a moisturizing effect, and has skin-beautifying effects such as skin aging suppression and skin quality improvement as a cosmetic (for example, patent document 1), prevention of pressure ulcer, and therapeutic effects (for example, patent document 2), prevention and improvement of atopic dermatitis (for example, patent document 3), anti-inflammatory, wound healing effect (For example, Non-Patent Document 1) is known.
- Patent Document 4 discloses an agent for imparting functionality to a fiber product containing amino acids
- Patent Document 5 discloses a fiber web.
- amino acids hydroxyproline or hydroxy is disclosed.
- Patent Document 1 International Publication No. OOZ51561 Pamphlet
- Patent Document 2 Pamphlet of International Publication No. 2004Z28531
- Patent Document 3 International Publication No. 02Z6225 Pamphlet
- Patent Document 4 Japanese Patent Application Laid-Open No. 2004-324026
- Patent Document 5 International Publication No. 96Z31644 Pamphlet
- Non-Patent Document 1 Eurobian Medical Research 3rd, 182-188, 1998 Invention Disclosure
- the present invention relates to an excellent function of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof for a fiber base material widely used for clothes, bedding, paper omgu, etc. An attempt was made to impart the excellent properties of the wood while keeping it intact, providing superior functional fiber products without drastically changing the conventional fiber manufacturing process and properties. The task is to do.
- the gist of the present invention is as follows.
- N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative. Sex imparting agent.
- N-acylated derivative power of hydroxyproline N-acetylated derivative, N-propionylated derivative, N-propylylated derivative or N-isoptyrylated derivative according to item 6 above ⁇ Bedding materials and products, interior materials and products, automotive interior materials and products, and nursing materials and products.
- N-acylated derivative of hydroxyproline is an N-acetylated derivative, an N-propionylated derivative, an N-propylylated derivative or an N-isoptyrylated derivative.
- the fiber product has functions such as moisture retention, skin aging prevention, skin quality improvement and other skin beautifying effects, pressure ulcer prevention, anti-atopic, anti-inflammatory and wound healing effects. It can be granted.
- the hydroxyproline used in the present invention may be any stereoisomer of hydroxyproline.
- proline of hydroxyproline has 8 physical isomers depending on whether it is D-strength L-strength or hydroxyl-position 3 or 4-position, and its stereoisomer is cis-force trans. And deviations of mixtures thereof can also be used in the present invention.
- hydroxyproline examples include cis-4-hydroxy-1-L-proline, cis-1-hydroxy-D-proline, cis-3-hydroxy-L-proline, cis-3-hydroxy-D-proline, trans-4-hydroxy-L-- Examples include proline, trans-4-hydroxy-D-proline, trans-1-hydroxy-L-proline, and trans-3-hydroxy-D phosphorus.
- Hydroxyproline is a kind of amino acid that exists widely in nature as a major constituent amino acid component in collagen and as a constituent amino acid of elastin.
- hydroxyproline acid-hydrolyzes collagen derived from animals such as butterfly. It can be produced by purification by a conventional method.
- Trans-4-hydroxy L-proline is a proline 4-hydroxylase isolated from microorganisms of the genus Amvcolatopsis or Dactvlosporangium (JP-A-7-313179). Can be used.
- cis-3 hydroxyl L proline can be produced using porphyrin 3-position hydroxylase (Japanese Patent Laid-Open No. 7-322885) isolated from Streptomyces genus cattle. Yes, Bioindustry 1, 14 ⁇ , 31 (1997).
- Hydroxyproline produced using the above-mentioned microorganism-derived enzyme has excellent quality. It is more preferable as hydroxyproline used in the present invention.
- Examples of the N-acyl yl derivatives of hydroxyproline used in the present invention include the above-mentioned N-acyl yl derivatives of the various hydroxyproline stereoisomers.
- Examples of the acyl group of the N-acyl derivative include preferably an acyl group having 1 to 24 carbon atoms, more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms.
- Honoleminole acetinole, propionyl, butyrinole, isobutyryl, norellinore, pivalol, hexanol, heptanol, otatanyl, nonanoyl, decanol, undecanol, dodecanol, etc.
- Examples of the salt of hydroxyproline or N-acylated derivative of hydroxyproline include alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and magnesium, ammonium salts, Examples thereof include addition salts of amines such as monoethanolamine, diethanolamine, triethanolamine and triisopropanolamine, and addition salts of basic amino acids such as arginine and lysine.
- N-acyl derivative of hydroxyproline can be prepared by a known method.
- N-acyl derivatives of hydroxyproline are linear or branched saturated fatty acids having 1 to 24 carbon atoms, such as chlorides and bromides using halogenating agents such as salt and phosgene.
- the product can be produced by conversion to a halogenated product such as the above, followed by condensation with hydroxyproline as described above, or conversion of a fatty acid to an acid anhydride followed by reaction with hydroxyproline.
- fatty acids include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and undehydroacid.
- a fatty acid such as dodecanoic acid is used alone or in combination.
- the fatty acid is dispersed in a solvent such as methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, xylene, n-hexane, etc., and 1 to 5 times equivalent of a halogenating agent is added thereto to react.
- a solvent such as methylene chloride, chloroform, carbon tetrachloride, benzene, toluene, xylene, n-hexane, etc.
- Examples of the solvent used in the acyl chloride reaction include water, methanol, ethanol, isopropanol, isobutanol, acetone, toluene, tetrahydrofuran, ethyl acetate, N, N dimethylformamide, dimethyl sulfoxide, and the like. May be used alone or in combination.
- hydroxyproline is dissolved or dispersed in a solvent, 0.8 to 2.0 times equivalent of alkaline substance such as sodium hydroxide and potassium hydroxide is dissolved in the solvent as necessary. Alternatively, it may be dispersed.
- N-acylated derivative of hydroxyproline When it is desired to obtain a salt of an N-acylated derivative of hydroxyproline, if the N-acylated derivative of hydroxyproline is obtained in the form of a salt, it can be purified as it is and obtained in a free form. May be dissolved or suspended in a suitable solvent and a base may be added to form a salt.
- N-acylated derivatives of hydroxyproline include, for example, N-acetyl-cis-4-hydroxy-1-L-proline, N-acetylenolysis-1-4-hydroxy-1-D-proline, N- 1-hydroxyl L-proline, N-acetylenic 1-hydroxy D-proline, N-acetylenic trans 4-4-hydroxy L-proline, N-acetylin trans 4-hydroxy D-proline, N-acetylinole trans 3-hydroxyl-proline, N-acetylinole -Trans 3-hydroxy D proline, N-propionyl-cis 4-hydroxy-L-proline, N-propionyl-cis-4-hydroxy-D-proline, N-propionyl-cis 3-hydroxy L proline, N propionyl cis 3 —Hydroxy D—proline, N propionyl trans 4-hydroxy L— Proline, N-propioninoletrans 4-hydroxy D pulin, N-propion
- the function-imparting agent of the present invention preferably contains 0.01 to 30% by weight of hydroxyproline, a hydroxyproline N-acylated derivative or a salt thereof.
- the functionality-imparting agent of the present invention includes, for example, a stabilizer such as hydroxyproline or a N-calyzed derivative of hydroxyproline or a salt thereof of 0.01 to 30 parts by weight, necessary sorbitol or sorbitol. 0.1 to 10 parts by weight, for example, antiseptic of isothiazoline-based antibacterial agents such as 5-clonal 2-methyl-4-isothiazolin-1-one and 2-methyl-4-isothiazolin-1-one compound (trade name: caisson) Preparation is made with 0.05 to 0. 3 parts by weight of the agent, 0.5 to 25 parts by weight of the binder, and 100 parts by weight of water.
- a stabilizer such as hydroxyproline or a N-calyzed derivative of hydroxyproline or a salt thereof of 0.01 to 30 parts by weight, necessary sorbitol or sorbitol.
- 0.1 to 10 parts by weight for example, antiseptic of isothiazoline-based antibacterial agents such as
- the functionality-imparting agent of the present invention further includes peptides, hydroxyproline or amino acid derivatives other than salts of hydroxyproline or its salts, vitamins, ceramides, glycyrrhizic acids of licorice extract, and raspberries. Extract, lavender extract, jasmine extract, peno mint extract, rosemary extract, roman force fir mono extract, eucalyptus extract, hinokitiol, bamboo extract, aloe extract, catechin, grape funoles extract, lemon extract, jojoba oil, olive oil Citrus oil, seaweed extract, squalene, collagen, and at least one selected from the group power that also has glucose strength may be combined.
- Examples of the peptide include silk protein, hive mouth-in, and the like, and examples of the amino acids include glutamic acid, aspartic acid, glycine, cystine, serine, histidine, lysine, arginine, leucine and the like. It is not limited to. As the vitamins, vitamin A, vitamin C, vitamin E, etc. can be used effectively. Examples of the glycyrrhizic acid of Kiss include glycyrrhizic acid, glycyrrhetinic acid, sodium glycyrrhizinate, potassium glycyrrhizinate, and ammonium glycyrrhizinate.
- examples of the raspberries include raspberries and raspberry ketones
- examples of the squalans include squalans and squalene
- examples of the glucose include glucose, xylitol, and erythritol.
- antibacterial agents such as chitin and chitosan may be combined.
- the combination strength S with silk protein, hive mouth-in, screen lantern, and the like, clothing, etc. is particularly preferable because a very characteristic soft and volumey texture can be obtained.
- components such as hydroxyproline or a hydroxyproline N-acyl yl derivative or a salt thereof may be used in a normal state. It may be used as a clathrate or vesicle structure with dextrin.
- the vesicle structure utilizes a surfactant that forms a polymer at a specific concentration.
- the surfactant molecule aggregate that is, the vesicle bag-like bilayer membrane, has an aqueous phase inside. And has an oil phase. In the oil phase, an oily compound or the like is dissolved in a solvent such as benzyl benzoate and held in the oil phase portion of the vesicle structure.
- the functionality-imparting agent of the present invention contains a binder, it can be fixed to a fiber product as it is, and when it does not contain a binder, it can be fixed using a separate binder.
- the binder include acrylic ester-based, for example, Pararesin GH-S manufactured by Ohara Paradum Chemical Co., Ltd., urethane-based binders, for example, Parasol PN-20 manufactured by Ohara Paradum Chemical Co., Ltd., silicone binders such as Toray Silicone Co., Ltd. It is preferable to use Toray Silicone BY22-826 made by the company and other polymers such as fluorine and epoxy.
- the amount of the binder used is preferably 0.5 to 25 parts by weight relative to 0.01 to 30 parts by weight of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof.
- such a functionality-imparting agent is fixed to a fiber product, and the fiber product is retained.
- Functionality such as moisture, skin aging control and skin improvement, anti-atopy, anti-inflammatory, wound healing effect, pressure ulcer prevention, etc. can be added.
- Use a treatment solution containing a binder attach it to textiles using a known method such as dubbing, padding, coating, spraying, etc., and fix it dry!
- the fiber product to be treated is not particularly limited in terms of the type of fiber, such as yarn, woven fabric, knitted fabric, non-woven fabric, and fiber web, which may be misaligned.
- the adhesion amount of the function-imparting agent to the fiber product is not particularly limited, but is usually about 0.05 to 5% by weight, preferably 1 to 3% by weight in terms of solid content.
- the building materials of the present invention 'bedding materials and products, interior materials and products, automotive interior materials and products, care materials and products are hydroxyproline, N-acylated derivatives of hydroxyproline or salts thereof Indicates fabric, blanket, sheets, chair fabric, carpet, car seat fabric, seat cover, etc., which are bonded to fibers such as cotton ⁇ %, cotton Z polyester blend, hemp Z polyester blend, etc. Any of the hydroxyproline, the N-acylated derivative of hydroxyproline or a salt thereof may be used in the article. It is preferable to use hydroxyproline, acetyl hydroxyproline and the like.
- the garment of the present invention is hydroxyproline or a hydroxyproline N-acylation derivative or a salt thereof made of 100% cotton, 100% polyester, cotton Z polyester blend, 100% nylon, cotton Z nylon blend.
- the cloth ommu, paper ommu, wet tissue, and tissue paper of the present invention use hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof, and cotton woven paper and paper ommu are usually used for the cloth ommu.
- the water-absorbent fats and oils (see Japanese Patent Application Laid-Open No. 9-157543) and the wet tissue are those produced by bonding to paper. It may also be used in combination with antibacterial agents and deodorizers that are highly safe and natural products, antibacterial agents such as silver colloids, and deodorants.
- Cloth, paper, wet tissue, tissue paper Any hydroxyproline or hydroxyproline N-acylated derivative or salt thereof may be used for par, but hydroxyproline, acetyl hydroxyproline, etc. are preferably used.
- silicone resin as binder Toray Silicone Co., Ltd. manufactured by Toray Silicone BY22-826; the same shall apply hereinafter
- a cotton plain fabric with a basis weight of 300 gZm 2 was dipped in a solution obtained by diluting the above-mentioned functionality-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala so as to obtain a pickup rate of 100%. And pre-dried. Next, it was heat treated at 170 ° C. for 3 minutes to obtain a nursing sheet. This product has a pressure ulcer prevention effect and is very useful as a nursing sheet.
- a cotton denim woven fabric with a basis weight of 300 gZm 2 was immersed in a solution obtained by diluting the above-described function-imparting agent with water so as to be lOOgZL, and then squeezed with a mandala to obtain a pickup rate of 100%. Pre-dried with C. Next, it was heat treated at 170 ° C. for 3 minutes and sewed onto jeans. This product has a moisturizing and skin-beautifying effect and is very useful as a functional clothing.
- Example 3 N-acetyl-trans-1, 4-hydroxy-1, L-proline, 10 parts of squalane silica microcapsule, 15 parts of ethanol, 10 parts of ethylene oxide of lauryl alcohol, 10 parts of an adduct, 20 parts of silicone resin as a binder, The remainder was made up to 100 parts with water to make a functionality imparting agent for fiber webs.
- Example 3 Instead of N-acetylenotrans 4-hydroxy-L proline in Example 3, the amount of water used was increased to make a total of 100 parts.
- Example 3 The wet tissue obtained in Example 3 and Comparative Example 1 was applied to the elbow part, covered with a nylon film, and stopped with an adhesive tape for upper skin, allowed to stand for 4 hours, and then the skin was removed with a microscope.
- the product of Example 3 showed a skin beautifying effect such as improvement in skin quality
- the product of Comparative Example 1 was powerful without showing a skin beautifying effect.
- the present invention is used in the field of functional fiber products.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Textile Engineering (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Bedding Items (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Mattresses And Other Support Structures For Chairs And Beds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention propose un agent destiné à communiquer à des produits textiles certaines fonctions telles que, par exemple, l'humidification, le ralentissement du vieillissement de la peau, l'amélioration des propriétés de la peau, la prévention des escarres, des effets thérapeutiques, la prévention et le traitement de la dermatite atopique, des effets anti-inflammatoires, la guérison des blessures, etc. L'invention concerne donc un agent destiné à communiquer certaines fonctions à des produits textiles, ledit agent contenant de l'hydroxyproline, un dérivé acylé de l'hydroxyproline ou un sel de celle-ci, et des produits textiles fonctionnels à utiliser avec l'agent destiné à communiquer des fonctions tel que décrit plus haut, en particulier des matériaux et des articles d'architecture, de literie, de décoration domestique, d'aménagement intérieur d'automobiles, de soins infirmiers, des vêtements, des couches en tissu, des couches en papier jetables, des mouchoirs en papier et du papier de soie.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007528169A JPWO2006120851A1 (ja) | 2005-05-02 | 2006-04-19 | 繊維製品への機能性付与剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-134124 | 2005-05-02 | ||
JP2005134124 | 2005-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006120851A1 true WO2006120851A1 (fr) | 2006-11-16 |
Family
ID=37396364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/308214 WO2006120851A1 (fr) | 2005-05-02 | 2006-04-19 | Agent destine a communiquer des fonctions a des produits textiles |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2006120851A1 (fr) |
WO (1) | WO2006120851A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008126782A1 (fr) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Agent antiseptique cutané |
JP2009270208A (ja) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | 繊維用抗菌防臭加工剤並びに該加工剤で加工処理されてなる繊維製品。 |
US8338404B2 (en) * | 2007-09-11 | 2012-12-25 | Kyowa Hakko Bio Co., Ltd. | Composition and method for reducing allergen |
ITVR20120104A1 (it) * | 2012-05-22 | 2013-11-23 | Paolo Srl O | Procedimento di trattamento di tessuti destinati ad andare a contatto col corpo umano |
WO2014007290A1 (fr) * | 2012-07-03 | 2014-01-09 | 味の素株式会社 | Hydratant et produit cosmétique le comprenant |
JP2018202170A (ja) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | 吸収性物品 |
JP2018202165A (ja) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | 吸収性物品 |
WO2019012744A1 (fr) | 2017-07-14 | 2019-01-17 | 信越化学工業株式会社 | Fibres comprenant un agent fonctionnel, et procédé de fabrication de celles-ci |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5598978A (en) * | 1979-01-18 | 1980-07-28 | Keizou Ogino | Dyeing of polyamide product |
JPS58212447A (ja) * | 1982-05-26 | 1983-12-10 | シ−トン・カンパニ− | 凝集性,多孔質コラ−ゲンシ−ト材料の製造方法 |
JPS62110977A (ja) * | 1985-11-11 | 1987-05-22 | 日本油脂株式会社 | パ−ル状柔軟剤組成物 |
JP2000178881A (ja) * | 1998-12-15 | 2000-06-27 | Fuji Spinning Co Ltd | セルロース系布帛の加工法 |
WO2000051561A1 (fr) * | 1999-03-02 | 2000-09-08 | Kyowa Hakko Kogyo Co., Ltd. | Produits cosmetiques |
WO2003018073A2 (fr) * | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Article absorbant presentant une region de type film qui contient du chitosane et procede de fabrication associe |
-
2006
- 2006-04-19 JP JP2007528169A patent/JPWO2006120851A1/ja active Pending
- 2006-04-19 WO PCT/JP2006/308214 patent/WO2006120851A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5598978A (en) * | 1979-01-18 | 1980-07-28 | Keizou Ogino | Dyeing of polyamide product |
JPS58212447A (ja) * | 1982-05-26 | 1983-12-10 | シ−トン・カンパニ− | 凝集性,多孔質コラ−ゲンシ−ト材料の製造方法 |
JPS62110977A (ja) * | 1985-11-11 | 1987-05-22 | 日本油脂株式会社 | パ−ル状柔軟剤組成物 |
JP2000178881A (ja) * | 1998-12-15 | 2000-06-27 | Fuji Spinning Co Ltd | セルロース系布帛の加工法 |
WO2000051561A1 (fr) * | 1999-03-02 | 2000-09-08 | Kyowa Hakko Kogyo Co., Ltd. | Produits cosmetiques |
WO2003018073A2 (fr) * | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Article absorbant presentant une region de type film qui contient du chitosane et procede de fabrication associe |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008126782A1 (fr) * | 2007-04-06 | 2008-10-23 | Kyowa Hakko Bio Co., Ltd. | Agent antiseptique cutané |
JP5424869B2 (ja) * | 2007-04-06 | 2014-02-26 | 協和発酵バイオ株式会社 | 皮膚消毒剤 |
US8338404B2 (en) * | 2007-09-11 | 2012-12-25 | Kyowa Hakko Bio Co., Ltd. | Composition and method for reducing allergen |
JP2009270208A (ja) * | 2008-05-01 | 2009-11-19 | Ohara Palladium Kagaku Kk | 繊維用抗菌防臭加工剤並びに該加工剤で加工処理されてなる繊維製品。 |
ITVR20120104A1 (it) * | 2012-05-22 | 2013-11-23 | Paolo Srl O | Procedimento di trattamento di tessuti destinati ad andare a contatto col corpo umano |
WO2014007290A1 (fr) * | 2012-07-03 | 2014-01-09 | 味の素株式会社 | Hydratant et produit cosmétique le comprenant |
US9456971B2 (en) | 2012-07-03 | 2016-10-04 | Ajinomoto Co., Inc. | Moisturizer and cosmetic agent containing same |
JP2018202170A (ja) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | 吸収性物品 |
JP2018202165A (ja) * | 2017-06-02 | 2018-12-27 | 三洋化成工業株式会社 | 吸収性物品 |
WO2019012744A1 (fr) | 2017-07-14 | 2019-01-17 | 信越化学工業株式会社 | Fibres comprenant un agent fonctionnel, et procédé de fabrication de celles-ci |
KR20200029446A (ko) | 2017-07-14 | 2020-03-18 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 기능제 함유 섬유 및 그 제조 방법 |
US11834779B2 (en) | 2017-07-14 | 2023-12-05 | Shin-Etsu Chemical Co., Ltd. | Functional-agent-containing fiber and method for manufacturing same |
Also Published As
Publication number | Publication date |
---|---|
JPWO2006120851A1 (ja) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006120851A1 (fr) | Agent destine a communiquer des fonctions a des produits textiles | |
CN102803588B (zh) | 含碘以及直链淀粉的纤维、其制造方法及其应用 | |
JP3256210B2 (ja) | 繊維処理剤及び繊維の処理方法 | |
KR20130066581A (ko) | 섬유 및/또는 직물 재료의 처리 방법 | |
JP7317822B2 (ja) | 絹フィブロインを含むヘアケア組成物 | |
US20050054251A1 (en) | Undergarments containing active substances | |
JP2010090523A (ja) | 繊維構造物の抗菌防臭・制菌加工方法 | |
JP3038202B1 (ja) | 機能性繊維、その製造方法及び機能性繊維の加工溶液 | |
KR102181905B1 (ko) | 세탁용 이염 방지 살균 티슈의 제조방법 및 그 방법에 의한 티슈 | |
US20250230203A1 (en) | Fibroin peptides and protein fragments compositions | |
JP2004324026A (ja) | 機能性付与剤、及びそれを使用した機能性ある繊維製品の製造方法 | |
JP2000226777A (ja) | 角質層の新陳代謝を促進する被服並びにマイクロカプセルの付着方法 | |
JP2004067586A (ja) | 抗菌剤組成物及びそれを用いた抗菌性シート状物品 | |
TWI279226B (en) | Dressings which can be applied several times to textile fibres and textile fabrics | |
JP2001172861A (ja) | 繊維へ機能性薬剤を固着するための方法および組成物 | |
KR20040085417A (ko) | 섬유유연제 조성물 | |
JP5621223B2 (ja) | デオドラント剤 | |
JP3893116B2 (ja) | アレルゲン低減化剤 | |
EP1550705A1 (fr) | Inactivateur d'allergenes | |
JP2001020179A (ja) | 繊維材料 | |
BR112017011730B1 (pt) | processo cosmético de tratamento de odores do corpo humano, polímero, composição e processos de desodorização | |
JP2006307380A (ja) | 繊維用加工剤ならびにそれを用いた繊維製品 | |
JP4093838B2 (ja) | 繊維用処理剤および繊維材料 | |
JPH06322670A (ja) | 繊維の加工法 | |
JPH11107163A (ja) | 繊維処理剤、繊維または繊維素材生地、および衛生用品表面材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007528169 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06745446 Country of ref document: EP Kind code of ref document: A1 |